Evolus to Report Third Quarter Financial Results on November 6, 2024
Evolus (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio of consumer brands, has scheduled its third quarter 2024 financial results release for November 6, 2024, after U.S. market close. Management will host a conference call and webcast at 4:30 p.m. ET the same day, including a Q&A session. Investors can join via phone or webcast through the company's Investor Relations page.
Evolus (NASDAQ: EOLS), una azienda nel settore della bellezza performante focalizzata sulla creazione di un portfolio estetico di marchi di consumo, ha programmato la pubblicazione dei risultati finanziari del terzo trimestre 2024 per 6 novembre 2024, dopo la chiusura del mercato statunitense. La direzione terrà una conference call e un webcast alle 16:30 ET dello stesso giorno, comprendente una sessione di domande e risposte. Gli investitori possono partecipare tramite telefono o webcast attraverso la pagina delle Relazioni con gli Investitori dell'azienda.
Evolus (NASDAQ: EOLS), una empresa de belleza enfocada en construir un portafolio estético de marcas de consumo, ha programado la publicación de sus resultados financieros del tercer trimestre de 2024 para el 6 de noviembre de 2024, después del cierre del mercado en EE. UU. La dirección llevará a cabo una llamada y un webcast a las 4:30 p.m. ET el mismo día, incluyendo una sesión de preguntas y respuestas. Los inversores pueden unirse por teléfono o webcast a través de la página de Relaciones con los Inversores de la empresa.
에볼루스 (NASDAQ: EOLS), 소비자 브랜드의 미적 포트폴리오 구축에 중점을 둔 성능 미용 회사는 2024년 3분기 재무 결과 발표를 2024년 11월 6일, 미국 시장 마감 후에 예정했습니다. 경영진은 같은 날 동부 표준시 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 개최할 예정이며, 질문 및 응답 세션도 포함됩니다. 투자자는 회사의 투자자 관계 페이지를 통해 전화 또는 웹캐스트로 참여할 수 있습니다.
Evolus (NASDAQ: EOLS), une entreprise de beauté performante axée sur la constitution d'un portefeuille esthétique de marques de consommation, a prévu de publier ses résultats financiers du troisième trimestre 2024 le 6 novembre 2024, après la fermeture du marché aux États-Unis. La direction organisera une conférence téléphonique et un webcast à 16h30, heure de l'Est, le même jour, incluant une session de questions-réponses. Les investisseurs peuvent se joindre par téléphone ou par webcast via la page des Relations Investisseurs de l'entreprise.
Evolus (NASDAQ: EOLS), ein Unternehmen im Bereich der Leistungs-Beauty mit dem Fokus auf den Aufbau eines ästhetischen Portfolios von Verbrauchermarken, hat die Veröffentlichung seiner Finanzergebnisse für das dritte Quartal 2024 für den 6. November 2024, nach Marktschluss in den USA, angesetzt. Das Management wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, die eine Fragerunde umfasst. Investoren können telefonisch oder über den Webcast über die Seite der Investor Relations des Unternehmens teilnehmen.
- None.
- None.
Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow management’s remarks.
To participate in the conference call, dial (877) 407-6184 (
Following the completion of the call, a telephonic replay can be accessed by dialing (877) 660-6853 (
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive
Jeuveau® and Nuceiva® are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Estyme® is a trademark of Symatese Aesthetics S.A.S.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241023091239/en/
Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email: ir@evolus.com
Media:
Email: media@evolus.com
Source: Evolus
FAQ
When will Evolus (EOLS) release Q3 2024 earnings?
How can investors join Evolus (EOLS) Q3 2024 earnings call?
What time is Evolus (EOLS) Q3 2024 earnings call?
